Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.114900
Revised: November 25, 2025
Accepted: January 4, 2026
Published online: February 15, 2026
Processing time: 128 Days and 21.9 Hours
The article by Han and associates highlights a frequently neglected consequence of type 2 diabetes mellitus (T2D): Dry eye disease associated with corneal neu
Core Tip: Dry eye disease in type 2 diabetes is not merely a surface ocular issue; it signifies underlying neurovascular and metabolic impairment. Han et al’s paper presents data correlating corneal nerve modifications with the severity of dry eye disease in patients with type 2 diabetes. Together with expanding findings on inflammatory biomarkers, immunological cross-talk, and global research trends, this body of evidence highlights the necessity to include ocular surface assessment into diabetes therapy. Future advancements will depend on precision medicine approaches, biomarker-directed screening, and medicines aimed at neuroinflammation and oxidative stress to maintain eyesight and enhance quality of life.
